HIIT holds no edge over steady cardio for PCOS

Polycystic ovary syndrome is the most prevalent endocrine disorder affecting women of reproductive age, and lifestyle change, particularly exercise, is a cornerstone of managing it. High-intensity interval training and moderate-intensity continuous training are both commonly recommended, yet high-quality evidence directly comparing them in women with PCOS has been limited. Interval training is often presented as the superior choice for metabolic health, so a fair head-to-head comparison in this group carries a genuinely practical stake: which style of cardio should a woman with PCOS choose, and does the harder option earn its reputation?

The authors searched PubMed, EMBASE, Web of Science and the Cochrane Library up to 15 April 2025 for randomised controlled trials directly comparing supervised HIIT with supervised moderate-intensity continuous training in premenopausal women aged 18 to 50 with diagnosed PCOS, where the intervention lasted at least 12 weeks. They extracted outcomes spanning body measurements, cardiorespiratory fitness, glucose and insulin metabolism, blood lipids and hormonal markers. Trial quality and overall confidence in the evidence were formally assessed, and six trials met the criteria for pooling.

No statistically significant superiority emerged for either training style on any outcome measured. Weight, BMI, waist circumference, hip circumference and waist-to-hip ratio did not differ, nor did VO2max or blood pressure. Fasting glucose, fasting insulin and insulin resistance were equivalent, as were total cholesterol, HDL, LDL and triglycerides, and hormone measures including testosterone, SHBG and the free androgen index. The consistency of the null across every single category is the notable feature. The authors graded the certainty of this evidence as very low to low, so the equivalence itself is not firmly established.

This challenges the assumption that higher intensity buys bigger metabolic returns for women with PCOS, at least across interventions of 12 weeks or longer. It also matches a broader pattern in exercise research, where interval and continuous training frequently deliver similar results when compared fairly against each other. The major caveat is scale: with only six trials and low to very low certainty, a real but modest difference could easily have been missed, and the authors call for larger randomised trials before treating the question as closed.

If you have PCOS, this is evidence that the choice between intervals and steady cardio can be driven by what you will actually keep doing, since neither approach showed superiority on weight, fitness, blood sugar, lipids or hormones. The authors themselves suggest either can be recommended based on personal preference. What this does not say is that exercise fails to help: these trials compared the two styles against each other, not against doing nothing at all.